NPPA fixes prices of 29 formulations under DPCO, check out details
Many of the drugs whose price has been fixed includes popular cardio-diabetes products, paracetemol combinations, and many more
New Delhi: Through a recent order the apex drug price controller, National Pharmaceutical Pricing Authority (NPPA) has fixed the price of 29 drug formulations. Many of the drugs whose price has been fixed includes popular cardio-diabetes products, paracetemol combinations, and many more
In the recent order issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of goods and services tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof:
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.)
|
(1) | (2) | (3) | (4) | (5) | (6) |
1. | Metoprolol Tablet | Each film-coated extended-release tablet contains: Metoprolol Succinate IP 95mg eq. to Metoprolol Tartrate 100mg | 1 Tablet | M/s Cipla Ltd. | 10.34 |
2. | Vildagliptin + Metformin Tablet (Vildaprime-M 50/500) | Each film-coated tablet contains: Vildagliptin 50mg, Metformin Hydrochloride IP 500mg, | 1 Tablet | M/s Swiss Garnier Genexia Sciences Pvt. Ltd. / M/s Primus Remedies Pvt. Ltd. | 6.17 |
3. | Vildagliptin + Metformin Tablet (Vildaprime-M 50/850) | Each film-coated tablet contains: Vildagliptin 50mg, Metformin Hydrochloride IP 850mg | 1 Tablet | M/s Swiss Garnier Genexia Sciences Pvt. Ltd. / M/s Primus Remedies Pvt. Ltd. | 6.24 |
4. | Vildagliptin + Metformin Tablet (Vildaprime-M 50/1000) | Each film-coated tablet contains: Vildagliptin 50mg, Metformin Hydrochloride IP 1000mg, | 1 Tablet | M/s Swiss Garnier Genexia Sciences Pvt. Ltd. / M/s Primus Remedies Pvt. Ltd. | 6.81 |
5. | Trypsin & Chymotripsin + Paracetamol + Aceclofenac Tablet (Zerodol TC
| Each film-coated tablet contains: 50,000 Armour Units Enzymatic Activity Supplied by purified concentrate which has specific Trypsin & Chymotripsin activity in a ratio of approximately six to One (as enteric-coated granuales) Paracetamol IP 325mg, Aceclofenac IP 100mg
| 1 Tablet | M/s Synokem Pharmaceuticals Ltd. / M/s Ipca Laboratories Ltd. | 8.29 |
6. | Emtricitabine + Tenofovir Alafenamide Tablet (TAFNAT-EM)
| Each film coated Tablet contains: Emtricitabine IP 200mg, Tenofovir Alafenamide Fumarate eq. to Tenofovir Alafenamide 25mg | 1 Tablet | M/s Natco Pharma Limited | 51.34 |
7. | Chlorpheniramine + Phenylephrine Syrup | Each ml syrup contains: Chlorpheniramine Maleate IP 2mg, Phenylephrine Hydrocloride IP 5mg
| Per ml | M/s Windlas Biotech Pvt. Ltd. / M/s Zydus Healthcare Limited | 0.90 |
8. | Chlorpheniramine + Phenylephrine Drops | Each ml drops contains: Chlorpheniramine Maleate Ip 1mg, Phenylephrine Hydrocloride IP 2.5mg | Per ml | M/s Windlas Biotech Pvt. Ltd. / M/s Zydus Healthcare Limited | 3.13 |
9. | Paracetamol + Chlorpheniramine + Phenylephrine Tablet | Each uncoated tablet contains: Paracetamol IP 500mg, Chlorpheniramine Maleate IP 2mg, Phenylephrine Hydrocloride IP 10mg | 1 Tablet | M/s Windlas Biotech Pvt. Ltd. / M/s Zydus Healthcare Limited | 3.29 |
10. | Atorvastatin + Clopidogrel + Aspirin Capsule | Each hard gelatine capsule contains: Atorvastatin Calcium IP eq. to Atorvastatin 10mg, Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg, Aspirin IP 75mg (As enteric coated pellets) | 1 Capsule | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Abbott Healthcare Pvt. Ltd
| 3.90 |
11. | Atorvastatin + Clopidogrel + Aspirin Capsule | Each hard gelatine capsule contains:Atorvastatin Calcium IP eq. to Atorvastatin 20mg,Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg,Aspirin IP 75mg (As enteric coated pellets) | 1 Capsule | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Abbott Healthcare Pvt. Ltd.
| 5.27
|
12. | Telmisartan + Cilnidipine + Metoprolol Tablet | Each film-coated Bilayered Tablet contains: Telmisartan IP 40mg Cilnidipine IP 10mg, Metoprolol Succinate IP 23.75mg eq. to Metoprolol Tartrate 25mg (As Extended-Release)
| 1 Tablet | M/s Micro Labs Limited | 9.64 |
13. | Telmisartan + Cilnidipine + Metoprolol Tablet | Each film-coated Bilayered Tablet contains: Telmisartan IP 40mg Cilnidipine IP 10mg, Metoprolol Succinate IP 47.50mg eq. to Metoprolol Tartrate 50mg (As Extended-Release) | 1 Tablet | M/s Micro Labs Limited | 11.96 |
14. | Tranexamic Tablet | Each Film-coated tablet contains: Tranexamic Acid IP 250mg
| 1 Tablet | M/s Pharma Synth Formulations Ltd/ M/s La Prisine Bioceuticals Pvt. Ltd
| 15.30 |
15. | Esomeprazole + Domperidone Capsule | Each hard gelatin capsule contains: Esomeprazole Magnesium Trihdrate IP eq. to Esomeprazole 40mg (as enteric coated pellets) Domperidone IP 30mg (as sustained release pellets) | 1 Capsule | M/s East African (India) Overseas / M/s Zydus Healthcare Limited | 8.94 |
16. | Teneligliptin + Metformin Tablet | Each uncoated bilayered tablet contains: Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin 20mg Metformin HCl 500mg (SR) | 1 Table
| M/s Synokem Pharmaceuticals Ltd. / M/s Apex Laboratories Private Limited | 10.45 |
17. | Sucralfate + Oxetacaine Suspension | Each 5ml suspension contains: Sucralfate IP 1gm, Oxetacaine BP 10mg | Per ml | M/s Pure & Cure Healthcare Pvt. Ltd. / Dr. Reddy's Laboratories Ltd. | 0.95 |
18. | Folic Acid + Methylcobalamin Tablet (FDSON-12 SL)
| Each uncoated tablet contains: Folic Acid IP 5mg, Methylcobalamin IP 750mcg | 1 Tablet | M/s Unison Pharmaceuticals Pvt. Ltd.
| 2.34 |
19. | Calcium Carbonate + Cholecalciferol Tablet (Macalvit Forte) | Each film-coated tablet contains: Calcium Carbonate IP 1.250g, eq. to Elemental Calcium 500mg, Cholecalciferol (Stabilized) eq. to Cholecalciferol IP 500IU (Vitamin D3) | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Novartis India Limited | 10.00 |
20. | Esomeprazole + Domperidone Capsule | Each hard gelatin capsule contains: Esomeprazole Magnesium Trihdrate IP eq. to Esomeprazole 40mg (as enteric coated pellets) Domperidone IP 30mg (as sustained release pellets)
| 1 Capsule
| M/s Nest Healthcare Pvt. Ltd. / M/s Cadila Pharmaceuticals Limited | 8.94 |
21. | Temisartan + Metoprolol Tablet | Each film-coated bilayered Tablet contains: Temisartan IP 40mg, Metoprolol Succinate IP 23.75mg eq. to Metoprolol Tartrate IP 25mg (As extended Release) | 1 Tablet | M/s Sun Pharma Laboratories Limited | 10.58 |
22. | Temisartan + Metoprolol Tablet | Each film-coated bilayered Tablet contains: Temisartan IP 40mg, Metoprolol Succinate IP 47.50mg eq. to Metoprolol Tartrate IP 50mg (As extended Release)
| 1 Tablet | M/s Sun Pharma Laboratories Limited
| 12.69 |
23. | Telmisartan + Chlorthalidone Tablet (Tamica-CT 40/6.25) | Each un-coated Bi-Layered tablet contains: Telmisartan IP 40mg, Chlorthalidone IP 6.25mg | 1 Tablet | M/s Theon Pharmaceuticals Ltd. / M/s Alkem Laboratories Ltd
| 7.82 |
24. | Domperidone + Naproxen Sodium Tablet | Each film coated tablet contains: Domperidone Maleate IP eq. to Domperidone 10mg, Naproxen Sodium USP 275mg eq. to Naproxen 250mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Torrent Pharmaceuticals Pvt. Ltd. | 4.78 |
25. | Domperidone + Naproxen Sodium Tablet | Each film coated tablet contains: Domperidone Maleate IP eq. to Domperidone 10mg, Naproxen Sodium USP 550mg eq. to Naproxen 500mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Torrent Pharmaceuticals Pvt. Ltd.
| 5.93 |
26. | Gliclazide + Metformin Hydrochloride Tablet | Each uncoated tablet contains: Gliclazide IP 80mg, Metformin Hydrochloride IP 500mg
| 1 Tablet | M/s Innova Captab Limited / M/s Abbott Healthcare Pvt. Ltd
| 6.86 |
27. | Thiocolchicoside + Aceclofenac + Paracetamol Tablet (Zerodol TH 4 Max)
| Each Film Coated Tablet contains: Thiocolchicoside IP 4mg, Aceclofenac IP 100mg, Paracetamol IP 325mg
| 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Ipca Laboratories Ltd. | 14.04 |
28. | Thiocolchicoside + Aceclofenac + Paracetamol Tablet (Zerodol TH 8 Max) | Each Film Coated Tablet contains: Thiocolchicoside IP 8mg, Aceclofenac IP 100mg, Paracetamol IP 325mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Ipca Laboratories Ltd. | 21.40 |
29. | Linezolid + Dextrose Water for Injection (GALLINI I.V.) | Each 100ml contains: Linezolid IP 200mg Dextrose Anhydrous IP 5g Water for Injection
| Per 300 ml pack | M/s Aishwarya Lifesciences / M/s Galpha Laboratories Limited | 342.08
|
Note:
(a) The manufacturer of the above-mentioned formulations i.e. "new drug" under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.
(b) The manufacturer may add goods and services tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above-said table.
(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.
(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
(e) The above mentioned retail price is applicable only to the individual manufacturer/marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation/revision as stipulated under DPCO, 2013 and subject to fulfillment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.
(f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.
(g) Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded.
To read the full article click on the following link:
https://business.medicaldialogues.in/pdf_upload/pdf_upload-126340.pdf
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd